• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Campbell Appoints Carrie Anderson Chief Financial Officer

    1/25/23 4:30:00 PM ET
    $CPB
    $EMBC
    $IART
    Packaged Foods
    Consumer Staples
    Medical/Dental Instruments
    Health Care
    Get the next $CPB alert in real time by email

    Campbell Soup Company (NYSE:CPB) today announced the appointment of Carrie L. Anderson as Executive Vice President and Chief Financial Officer, effective Feb. 6.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230125005725/en/

    Carrie Anderson (Photo: Business Wire)

    Carrie Anderson (Photo: Business Wire)

    Anderson will lead Campbell's finance function, including controllership, corporate financial planning and analysis, corporate strategy and development, tax, treasury, internal audit, investor relations, transactional services and financial systems. She will report to Campbell's President and Chief Executive Officer Mark Clouse and become a member of the company's Operating Committee and a Corporate Officer. Anderson succeeds Mick Beekhuizen, who was appointed President of Campbell's Meals & Beverages division in November 2022.

    "I am delighted to welcome Carrie to our leadership team. She brings a wide range of diverse, strategic experience and financial discipline, and her expertise in capital management and deployment will help us continue to drive our growth plans and enhance our performance," said Clouse. "Her collaborative approach combined with a track record of driving transformation, delivering results and developing strong finance teams will be invaluable as we continue to build momentum in the business."

    Anderson brings a wealth of financial experience working in a variety of complex industries, as well as a background in manufacturing and engineering. She joins Campbell from Integra LifeSciences (NASDAQ:IART), a leading global medical technology company, where she has served as Executive Vice President and Chief Financial Officer since 2019. Before Integra, Anderson spent seven years with Dover Corporation in several leadership roles, including Chief Accounting Officer/Corporate Controller, and Vice President and CFO for the company's engineered systems and printing and identification businesses. Previously, Anderson spent six years as Vice President and Chief Financial Officer of Delphi Product & Service Solutions, a division of Delphi Corporation. While at Delphi, she also held leadership positions in finance, treasury and investor relations. Anderson started her career with General Motors.

    Anderson earned her B.S. in chemical engineering from Purdue University and an MBA from Ball State University. She serves on the board of directors of Embecta Corp. (NASDAQ:EMBC) and is a member of its Audit and Nominating & Governance committees.

    About Campbell Soup Company

    For more than 150 years, Campbell (NYSE:CPB) has been connecting people through food they love. Generations of consumers have trusted Campbell to provide delicious and affordable food and beverages. Headquartered in Camden, N.J. since 1869, Campbell generated fiscal 2022 net sales of nearly $8.6 billion. Our portfolio includes iconic brands such as Campbell's, Cape Cod, Goldfish, Kettle Brand, Lance, Late July, Milano, Pace, Pacific Foods, Pepperidge Farm, Prego, Snyder's of Hanover, Swanson and V8. Campbell has a heritage of giving back and acting as a good steward of the environment. The company is a member of the Standard & Poor's 500 as well as the FTSE4Good and Bloomberg Gender-Equality Indices. For more information, visit www.campbellsoupcompany.com or follow company news on Twitter via @CampbellSoupCo.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20230125005725/en/

    Get the next $CPB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CPB
    $EMBC
    $IART

    CompanyDatePrice TargetRatingAnalyst
    The Campbell's Company
    $CPB
    8/20/2025$33.00Neutral
    Analyst
    The Campbell's Company
    $CPB
    8/7/2025$34.00Overweight → Neutral
    Piper Sandler
    The Campbell's Company
    $CPB
    6/20/2025Buy → Hold
    Argus
    The Campbell's Company
    $CPB
    4/23/2025$36.00Sell
    UBS
    Embecta Corp.
    $EMBC
    4/10/2025$15.00Neutral
    Mizuho
    Integra LifeSciences Holdings Corporation
    $IART
    3/31/2025Hold → Buy
    Argus
    The Campbell's Company
    $CPB
    3/17/2025Overweight → Equal Weight
    Consumer Edge Research
    The Campbell's Company
    $CPB
    3/6/2025$48.00 → $37.00Overweight → Neutral
    Analyst
    More analyst ratings

    $CPB
    $EMBC
    $IART
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Anderson Carrie L was granted 22,841 shares, increasing direct ownership by 55% to 64,581 units (SEC Form 4)

    4 - Embecta Corp. (0001872789) (Issuer)

    2/13/26 6:40:02 PM ET
    $EMBC
    Medical/Dental Instruments
    Health Care

    Director Hombach Robert J. was granted 22,841 shares, increasing direct ownership by 55% to 64,587 units (SEC Form 4)

    4 - Embecta Corp. (0001872789) (Issuer)

    2/13/26 6:36:15 PM ET
    $EMBC
    Medical/Dental Instruments
    Health Care

    Director Morris Milton Mayo was granted 22,841 shares, increasing direct ownership by 61% to 60,121 units (SEC Form 4)

    4 - Embecta Corp. (0001872789) (Issuer)

    2/13/26 6:31:56 PM ET
    $EMBC
    Medical/Dental Instruments
    Health Care

    $CPB
    $EMBC
    $IART
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Campbell's Appoints Mohit Anand President of Snacks Division

    Seasoned Global Food & Snacking Executive to Head Division of Iconic, Leading Snack Brands The Campbell's Company (NASDAQ:CPB) (Campbell's) today announced the appointment of Mohit Anand as Executive Vice President (EVP) and President, Snacks, effective Feb. 23, 2026. He will lead a portfolio of advantaged snack brands including Goldfish, Pepperidge Farm, Snyder's of Hanover, Lance, Kettle Brand, Cape Cod, Snack Factory and Late July. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260218881995/en/Mohit Anand Anand will report to Campbell's President and Chief Executive Officer Mick Beekhuizen and become a member of the company

    2/18/26 4:30:00 PM ET
    $CPB
    Packaged Foods
    Consumer Staples

    Integra LifeSciences Announces Key Executive Leadership Appointments

    PRINCETON, N.J., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced the appointment of Teshtar Elavia as corporate vice president and chief technology officer, a newly created position to lead research and development (R&D), including product and technology development, across the company. The company also announced the appointments of Michael Hutchinson as executive vice president, chief legal officer and secretary, and Kerri DiPietro as corporate vice president and chief quality officer. The creation of the chief technology officer (CTO) position underscores Integra's commitment to build

    2/17/26 8:30:00 AM ET
    $IART
    Medical/Dental Instruments
    Health Care

    embecta names new Chairman of the Board and Lead Independent Director

    PARSIPPANY, N.J., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (NASDAQ:EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that the Board of Directors (the "Board") of embecta has elected Devdatt "Dev" Kurdikar as Chairman of the Board and Dr. Claire Pomeroy as Lead Independent Director, effective immediately. These changes follow the previously announced retirement of LTG (Ret.) David F. Melcher, Non-Executive Chairman of the Board due to several commitments outside of his service to the Company. Kurdikar, 57, joined BD (Becton, Dickinson and Company) in 2021 to lead the diabete

    2/11/26 4:10:00 PM ET
    $EMBC
    Medical/Dental Instruments
    Health Care

    $CPB
    $EMBC
    $IART
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Graves Jeffrey A bought $102,150 worth of shares (9,000 units at $11.35), increasing direct ownership by 28% to 41,086 units (SEC Form 4)

    4 - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Issuer)

    11/6/25 4:05:46 PM ET
    $IART
    Medical/Dental Instruments
    Health Care

    Director Melcher David F bought $105,995 worth of shares (10,000 units at $10.60), increasing direct ownership by 13% to 86,681 units (SEC Form 4)

    4 - Embecta Corp. (0001872789) (Issuer)

    5/23/25 4:35:56 PM ET
    $EMBC
    Medical/Dental Instruments
    Health Care

    Director Melcher David F bought $177,646 worth of shares (13,000 units at $13.67), increasing direct ownership by 20% to 76,681 units (SEC Form 4)

    4 - Embecta Corp. (0001872789) (Issuer)

    2/25/25 4:26:16 PM ET
    $EMBC
    Medical/Dental Instruments
    Health Care

    $CPB
    $EMBC
    $IART
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Analyst resumed coverage on Campbell Soup with a new price target

    Analyst resumed coverage of Campbell Soup with a rating of Neutral and set a new price target of $33.00

    8/20/25 8:33:18 AM ET
    $CPB
    Packaged Foods
    Consumer Staples

    Campbell Soup downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded Campbell Soup from Overweight to Neutral and set a new price target of $34.00

    8/7/25 7:33:36 AM ET
    $CPB
    Packaged Foods
    Consumer Staples

    Campbell Soup downgraded by Argus

    Argus downgraded Campbell Soup from Buy to Hold

    6/20/25 8:05:51 AM ET
    $CPB
    Packaged Foods
    Consumer Staples

    $CPB
    $EMBC
    $IART
    SEC Filings

    View All

    Embecta Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Embecta Corp. (0001872789) (Filer)

    2/13/26 5:25:14 PM ET
    $EMBC
    Medical/Dental Instruments
    Health Care

    SEC Form 10-Q filed by Embecta Corp.

    10-Q - Embecta Corp. (0001872789) (Filer)

    2/5/26 11:26:03 AM ET
    $EMBC
    Medical/Dental Instruments
    Health Care

    Embecta Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Embecta Corp. (0001872789) (Filer)

    2/5/26 6:54:42 AM ET
    $EMBC
    Medical/Dental Instruments
    Health Care

    $CPB
    $EMBC
    $IART
    Leadership Updates

    Live Leadership Updates

    View All

    Campbell's Appoints Mohit Anand President of Snacks Division

    Seasoned Global Food & Snacking Executive to Head Division of Iconic, Leading Snack Brands The Campbell's Company (NASDAQ:CPB) (Campbell's) today announced the appointment of Mohit Anand as Executive Vice President (EVP) and President, Snacks, effective Feb. 23, 2026. He will lead a portfolio of advantaged snack brands including Goldfish, Pepperidge Farm, Snyder's of Hanover, Lance, Kettle Brand, Cape Cod, Snack Factory and Late July. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260218881995/en/Mohit Anand Anand will report to Campbell's President and Chief Executive Officer Mick Beekhuizen and become a member of the company

    2/18/26 4:30:00 PM ET
    $CPB
    Packaged Foods
    Consumer Staples

    Integra LifeSciences Announces Key Executive Leadership Appointments

    PRINCETON, N.J., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced the appointment of Teshtar Elavia as corporate vice president and chief technology officer, a newly created position to lead research and development (R&D), including product and technology development, across the company. The company also announced the appointments of Michael Hutchinson as executive vice president, chief legal officer and secretary, and Kerri DiPietro as corporate vice president and chief quality officer. The creation of the chief technology officer (CTO) position underscores Integra's commitment to build

    2/17/26 8:30:00 AM ET
    $IART
    Medical/Dental Instruments
    Health Care

    Campbell's Appoints Todd Cunfer Chief Financial Officer

    Established Finance Leader Brings Over Two Decades of Food Industry Experience The Campbell's Company (NASDAQ:CPB) (Campbell's) today announced the appointment of Todd Cunfer as Executive Vice President and Chief Financial Officer, effective Oct. 20, 2025. He will report to Campbell's President and Chief Executive Officer Mick Beekhuizen and become a member of the company's Operating Committee and an Executive Officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251007967740/en/Todd Cunfer "I am excited to welcome Todd to the Campbell's team," said Beekhuizen. "With more than two decades of food industry experience, he brin

    10/7/25 4:30:00 PM ET
    $CPB
    $FRPT
    $HSY
    Packaged Foods
    Consumer Staples
    Specialty Foods

    $CPB
    $EMBC
    $IART
    Financials

    Live finance-specific insights

    View All

    Integra LifeSciences to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 26, 2026

    PRINCETON, N.J., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, will release fourth quarter and full year 2025 financial results on Thursday, February 26, 2026, prior to the market open. In conjunction with the earnings release, Integra's management team will host a conference call at 8:30 a.m. ET. A live webcast will be available on the Investors section of the Company's website at investor.integralife.com. For those planning to participate on the call, register here to receive dial-in details and an individual pin. While not required, joining 10 minutes before the event starts is recommended. A webc

    2/9/26 6:35:00 AM ET
    $IART
    Medical/Dental Instruments
    Health Care

    Embecta Corp. Reports First Quarter Fiscal 2026 Financial Results

    PARSIPPANY, N.J., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (NASDAQ:EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today reported first quarter fiscal 2026 financial results. Visit the company's Investor Relations website at http://investors.embecta.com to view the detailed first quarter fiscal 2026 earnings press release and investor presentation. The company will host a conference call and live audio webcast for analysts and investors at 8:00 a.m. ET today, February 5, 2026, which is accessible here, or access the teleconference here. A webcast replay of the call will be available be

    2/5/26 6:30:00 AM ET
    $EMBC
    Medical/Dental Instruments
    Health Care

    embecta Announces Quarterly Cash Dividend

    PARSIPPANY, N.J., Feb. 05, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. ("embecta") (NASDAQ:EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding share of the Company's common stock. The dividend is payable on March 17, 2026 to stockholders of record at the close of business on February 27, 2026. About embecta embecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, helping to improve lives through innovative solutions, partnerships, and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social

    2/5/26 6:00:00 AM ET
    $EMBC
    Medical/Dental Instruments
    Health Care

    $CPB
    $EMBC
    $IART
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Integra LifeSciences Holdings Corporation

    SC 13G - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Subject)

    11/12/24 5:20:30 PM ET
    $IART
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Integra LifeSciences Holdings Corporation

    SC 13G/A - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Subject)

    11/12/24 12:54:20 PM ET
    $IART
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Embecta Corp.

    SC 13G/A - Embecta Corp. (0001872789) (Subject)

    11/8/24 10:57:43 AM ET
    $EMBC
    Medical/Dental Instruments
    Health Care